DexCom, Inc. NASDAQ:DXCM

DexCom stock price today

$81
+0.76
+0.95%
Financial Health
0
1
2
3
4
5
6
7
8
9

DexCom stock price monthly change

-29.65%
month

DexCom stock price quarterly change

-29.65%
quarter

DexCom stock price yearly change

-35.15%
year

DexCom key metrics

Market Cap
30.53B
Enterprise value
47.01B
P/E
140.29
EV/Sales
16.15
EV/EBITDA
83.16
Price/Sales
15.39
Price/Book
21.01
PEG ratio
1.16
EPS
1.66
Revenue
3.80B
EBITDA
867.3M
Income
639.3M
Revenue Q/Q
24.20%
Revenue Y/Y
25.78%
Profit margin
11.73%
Oper. margin
13.44%
Gross margin
64.72%
EBIT margin
13.44%
EBITDA margin
22.81%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

DexCom stock price history

DexCom stock forecast

DexCom financial statements

DexCom, Inc. (NASDAQ:DXCM): Profit margin
Jun 2023 871.3M 115.9M 13.3%
Sep 2023 975M 120.7M 12.38%
Dec 2023 1.03B 256.3M 24.78%
Mar 2024 921M 146.4M 15.9%
DexCom, Inc. (NASDAQ:DXCM): Analyst Estimates
Sep 2025 1.35B 266.84M 19.7%
Oct 2025 1.35B 270.70M 19.95%
Dec 2025 1.43B 293.35M 20.39%
Mar 2026 1.32B 229.26M 17.26%
  • Analysts Price target

  • Financials & Ratios estimates

DexCom, Inc. (NASDAQ:DXCM): Debt to assets
Jun 2023 6820700000 4.72B 69.21%
Sep 2023 6596200000 4.32B 65.62%
Dec 2023 6264500000 4.19B 66.98%
Mar 2024 6482200000 4.23B 65.34%
DexCom, Inc. (NASDAQ:DXCM): Cash Flow
Jun 2023 190.3M -555.9M 939.5M
Sep 2023 269.2M -179.5M -637.4M
Dec 2023 133.6M 414.9M -631.9M
Mar 2024 209.2M 74.8M 4.7M

DexCom alternative data

Dexcom G6 logo

Dexcom G6

Average rating: 3.7/5
Platform: Android
Store: Google Play
Type: Free
Market: United States
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Category:
DexCom, Inc. (NASDAQ:DXCM): Google Play Rank
Aug 2023 74
Sep 2023 70
Oct 2023 85
Nov 2023 79
Dec 2023 92
Jan 2024 84
Feb 2024 83
Mar 2024 84
Apr 2024 89
May 2024 88
Jun 2024 87
Dexcom Clarity logo

Dexcom Clarity

Average rating: 4.6/5
Platform: iOS
Store: App Store
Type: Free
Market:
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Category:
DexCom, Inc. (NASDAQ:DXCM): App Store Rank
Aug 2023 65
Sep 2023 60
Oct 2023 54
Nov 2023 41
Dec 2023 55
Jan 2024 49
Feb 2024 47
Mar 2024 48
Apr 2024 39
May 2024 34
Jun 2024 44
Dexcom Follow logo

Dexcom Follow

Average rating: 2.5/5
Platform: iOS
Store: App Store
Type: Free
Market: United States
Dexcom Follow app screenshot
Dexcom Follow app screenshot
Dexcom Follow app screenshot
Dexcom Follow app screenshot
Dexcom Follow app screenshot
Category:
DexCom, Inc. (NASDAQ:DXCM): App Store Rank
Aug 2023 70
Sep 2023 66
Oct 2023 83
Nov 2023 86
Dec 2023 68
Jan 2024 82
Feb 2024 76
Mar 2024 62
Apr 2024 74
May 2024 74
Jun 2024 53
Dexcom G6 logo

Dexcom G6

Average rating: 3/5
Platform: iOS
Store: App Store
Type: Free
Market: United States
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Dexcom G6 app screenshot
Category:
DexCom, Inc. (NASDAQ:DXCM): App Store Rank
Aug 2023 73
Sep 2023 69
Oct 2023 93
Nov 2023 89
Dec 2023 91
Jan 2024 100
Feb 2024 95
Mar 2024 88
Apr 2024 101
May 2024 114
Jun 2024 88
Dexcom Clarity logo

Dexcom Clarity

Average rating: 3.8/5
Platform: Android
Store: Google Play
Type: Free
Market:
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Dexcom Clarity app screenshot
Category:
DexCom, Inc. (NASDAQ:DXCM): Google Play Rank
Apr 2024 177
May 2024 179
Jun 2024 191
Dexcom Follow logo

Dexcom Follow

Average rating: 3/5
Platform: Android
Store: Google Play
Type: Free
Market: United States
Dexcom Follow app screenshot
Dexcom Follow app screenshot
Dexcom Follow app screenshot
Dexcom Follow app screenshot
Dexcom Follow app screenshot
Category:
DexCom, Inc. (NASDAQ:DXCM): Google Play Rank
Nov 2023 64
Dec 2023 61
Jan 2024 53
Feb 2024 54
Mar 2024 49
Apr 2024 45
May 2024 50
Jun 2024 55

DexCom Social Media Accounts

What are followers?
+0.46%
month
DexCom, Inc. (NASDAQ:DXCM): Followers count
May 2025 178596
Jul 2025 180078
Aug 2025 180908
+0.61%
month
+3.03%
quarter
DexCom, Inc. (NASDAQ:DXCM): Followers count
Aug 2023 197434
Sep 2023 198645

Areas of Focus

DexCom, Inc. (NASDAQ:DXCM): Google Trends - Areas of Focus
19 Feb 2023 72
26 Feb 2023 72
5 Mar 2023 73
12 Mar 2023 72
19 Mar 2023 78
26 Mar 2023 74
2 Apr 2023 76
9 Apr 2023 75
16 Apr 2023 74
23 Apr 2023 77
30 Apr 2023 74
7 May 2023 76
14 May 2023 74
21 May 2023 72
28 May 2023 86
4 Jun 2023 82
11 Jun 2023 74
18 Jun 2023 76
25 Jun 2023 70
2 Jul 2023 69

Dexcom

DexCom, Inc. (NASDAQ:DXCM): Google Trends - Dexcom
4 Aug 2024 52
11 Aug 2024 53
18 Aug 2024 48
25 Aug 2024 48
1 Sep 2024 47
8 Sep 2024 40
15 Sep 2024 40
22 Sep 2024 41
29 Sep 2024 39
6 Oct 2024 39
13 Oct 2024 41
20 Oct 2024 42
27 Oct 2024 44
3 Nov 2024 42
10 Nov 2024 45
17 Nov 2024 42
24 Nov 2024 40
1 Dec 2024 43
8 Dec 2024 42
15 Dec 2024 41

Dexcom Products

DexCom, Inc. (NASDAQ:DXCM): Google Trends - Dexcom Products
26 Feb 2023 0
5 Mar 2023 0
12 Mar 2023 0
19 Mar 2023 0
26 Mar 2023 0
2 Apr 2023 0
9 Apr 2023 0
16 Apr 2023 0
23 Apr 2023 0
30 Apr 2023 0
7 May 2023 0
14 May 2023 0
21 May 2023 0
28 May 2023 0
4 Jun 2023 0
11 Jun 2023 0
18 Jun 2023 0
25 Jun 2023 0
2 Jul 2023 0
9 Jul 2023 0

Diabetes Management

DexCom, Inc. (NASDAQ:DXCM): Google Trends - Diabetes Management
19 Feb 2023 59
26 Feb 2023 63
5 Mar 2023 54
12 Mar 2023 63
19 Mar 2023 82
26 Mar 2023 69
2 Apr 2023 75
9 Apr 2023 67
16 Apr 2023 76
23 Apr 2023 77
30 Apr 2023 76
7 May 2023 63
14 May 2023 66
21 May 2023 65
28 May 2023 67
4 Jun 2023 72
11 Jun 2023 67
18 Jun 2023 63
25 Jun 2023 65
2 Jul 2023 61

Numbers represent search interest relative to the highest point on the chart for the given region and time.

A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.

DexCom, Inc. (NASDAQ:DXCM): Job openings
Aug 2023 263
Sep 2023 274
Oct 2023 375
Nov 2023 262
Dec 2023 267
Jan 2024 432
Feb 2024 301
Apr 2024 341
May 2024 300
Jun 2024 347
Jul 2024 298
DexCom, Inc. (NASDAQ:DXCM): Employee count
Aug 2023 7,500
Sep 2023 7,500
Oct 2023 7,500
Nov 2023 7,500
Dec 2023 7,500
Jan 2024 7,500
Feb 2024 7,500
Mar 2024 9,500
Apr 2024 9,500
May 2024 9,500
Jun 2024 9,500
Jul 2024 9,500

DexCom other data

92.77% +1.77%
of DXCM is owned by hedge funds
371.46M +5.64M
shares is hold by hedge funds

DexCom, Inc. (NASDAQ:DXCM): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 48507
Feb 2024 0 3363
Mar 2024 0 158865
Apr 2024 0 52252
May 2024 0 3075
Jun 2024 0 9576
Jul 2024 0 652
Aug 2024 0 686
Sep 2024 0 2918
Nov 2024 0 7759
Dec 2024 0 2912
Transaction Date Insider Security Shares Price per share Total value Source
Sale
STERN SADIE officer: EVP, Chief HR Officer
Common Stock 424 $76.87 $32,593
Sale
SYLVAIN JEREME M officer: EVP, Chief Financal Of..
Common Stock 744 $76.87 $57,191
Sale
LEACH JACOB STEVEN officer: EVP, Chi.. Common Stock 744 $76.87 $57,191
Sale
HELLER BRIDGETTE P director
Common Stock 1,000 $76.87 $76,870
Sale
STERN SADIE officer: EVP, Chief HR Officer
Common Stock 4,259 $74.73 $318,275
Sale
SYLVAIN JEREME M officer: EVP, Chief Financal Of..
Common Stock 3,500 $75.51 $264,285
Sale
HELLER BRIDGETTE P director
Common Stock 1,000 $70 $70,000
Sale
STERN SADIE officer: EVP, Chief HR Officer
Common Stock 426 $69.15 $29,458
Sale
SYLVAIN JEREME M officer: EVP, Chief Financal Of..
Common Stock 746 $69.15 $51,586
Sale
LEACH JACOB STEVEN officer: EVP, Chi.. Common Stock 746 $69.15 $51,586
Patent
Grant
Filling date: 5 Jun 2018 Issue date: 6 Sep 2022
Grant
Filling date: 1 Feb 2017 Issue date: 6 Sep 2022
Application
Filling date: 18 May 2022 Issue date: 1 Sep 2022
Application
Filling date: 13 May 2022 Issue date: 1 Sep 2022
Grant
Filling date: 30 Jun 2020 Issue date: 30 Aug 2022
Grant
Filling date: 21 Nov 2018 Issue date: 30 Aug 2022
Application
Filling date: 23 Feb 2022 Issue date: 25 Aug 2022
Application
Filling date: 4 Oct 2021 Issue date: 25 Aug 2022
Grant
Filling date: 27 Aug 2021 Issue date: 16 Aug 2022
Grant
Filling date: 30 May 2019 Issue date: 16 Aug 2022
Monday, 23 December 2024
reuters.com
zacks.com
Saturday, 21 December 2024
fool.com
Friday, 20 December 2024
zacks.com
Thursday, 19 December 2024
businesswire.com
Wednesday, 18 December 2024
zacks.com
Tuesday, 17 December 2024
cnbc.com
businesswire.com
businesswire.com
Friday, 13 December 2024
zacks.com
Tuesday, 10 December 2024
seekingalpha.com
Thursday, 5 December 2024
seekingalpha.com
Monday, 2 December 2024
fool.com
Thursday, 28 November 2024
fool.com
Tuesday, 26 November 2024
zacks.com
fool.com
Sunday, 24 November 2024
fool.com
Friday, 22 November 2024
zacks.com
Tuesday, 19 November 2024
barrons.com
youtube.com
reuters.com
businesswire.com
Thursday, 14 November 2024
businesswire.com
Tuesday, 12 November 2024
youtube.com
Friday, 8 November 2024
fool.com
Monday, 28 October 2024
zacks.com
Friday, 25 October 2024
fool.com
benzinga.com
zacks.com
barrons.com
  • What's the price of DexCom stock today?

    One share of DexCom stock can currently be purchased for approximately $81.

  • When is DexCom's next earnings date?

    Unfortunately, DexCom's (DXCM) next earnings date is currently unknown.

  • Does DexCom pay dividends?

    No, DexCom does not pay dividends.

  • How much money does DexCom make?

    DexCom has a market capitalization of 30.53B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.49% to 3.62B US dollars.

  • What is DexCom's stock symbol?

    DexCom, Inc. is traded on the NASDAQ under the ticker symbol "DXCM".

  • What is DexCom's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of DexCom?

    Shares of DexCom can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are DexCom's key executives?

    DexCom's management team includes the following people:

    • Mr. Kevin Ronald Sayer Executive Chairman, Chief Executive Officer & Pres(age: 67, pay: $2,630,000)
    • Mr. Jacob Steven Leach Executive Vice President & Chief Technology Officer(age: 47, pay: $1,000,000)
  • How many employees does DexCom have?

    As Jul 2024, DexCom employs 9,500 workers.

  • When DexCom went public?

    DexCom, Inc. is publicly traded company for more then 20 years since IPO on 14 Apr 2005.

  • What is DexCom's official website?

    The official website for DexCom is dexcom.com.

  • Where are DexCom's headquarters?

    DexCom is headquartered at 6340 Sequence Drive, San Diego, CA.

  • How can i contact DexCom?

    DexCom's mailing address is 6340 Sequence Drive, San Diego, CA and company can be reached via phone at 858 200 0200.

DexCom company profile:

DexCom, Inc.

dexcom.com
Exchange:

NASDAQ

Full time employees:

9,500

Industry:

Medical - Devices

Sector:

Healthcare

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

6340 Sequence Drive
San Diego, CA 92121

CIK: 0001093557
ISIN: US2521311074
CUSIP: 252131107